Learn, Analyse & Invest
only with
only with
+91
Download Orca
Genpharmasec Ltd.
Genpharmasec
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹64.79 Cr.
| EX-Date | Purpose |
|---|---|
| 29 06 2021 | Audited Results |
| 12 08 2021 | Quarterly Results Inter alia, to consider the appointment of M/s. Meenakshi Manish Jain & Associates, Chartered Accountants, as an Internal Auditor of the Company for financial year 2021-2022. |
| 11 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 27 05 2022 | Audited Results & Quarterly Results |
| 10 08 2022 | Quarterly Results & Inter alia, To discuss and consider the matter of revision in remuneration of Mr. Ulhas Narayan Deosthale, Whole Time Director & CFO of the Company. |
| 01 11 2022 | Inter-alia, to transact the following businesses: 1. To consider and approve the Appointment of Independent Directors [Additional Director]; 2. To consider and take on record the resignation of Mr. Ulhas Deosthale from the post of Chief Financial Officer (CFO); 3. To consider and approve the appointment of Chief Financial Officer in place of Mr. Ulhas Deosthale; 4. Any other business with the permission of Chairperson. |
| 11 11 2022 | Quarterly Results |
| 28 12 2022 | Inter-alia, to consider:- 1. To consider and approve the Notice for Postal Ballot for the appointment of two new Independent Directors under Regulation 17(1C) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. To consider and approve the Calendar of events for Postal Ballot. 3. To consider and approve the appointment of Mr. Jaymin Modi, Practicing Company Secretary to act as Scrutinizer for E-voting at ensuing Postal Ballot Meeting. 4. To take on records Company has fixed 23rd December, 2022 as the CUT-OFF DATE to ascertain the eligibility of the members of the Company to cast their votes for Postal Ballot of the Company. 5. Any other business matter with the permission of the Chair. |
| 10 02 2023 | Quarterly Results |
| 30 03 2023 | Independent Director Meeting |
| 08 05 2023 | Increase in Authorised Capital |
| 26 05 2023 | Audited Results |
| 05 06 2023 | Inter alia, to consider and approve the proposal for raising of funds by issuance of equity share or convertible bonds or debentures or any other securities, through permissible modes including but not limited to a rights issue, preferential issue or qualified institutions placement, as may be permitted under applicable law and subject to such regulatory/ statutory approvals, as may be required and any other Matter with the permission of the Chairman. |
| 11 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 26 03 2024 | Independent Director Meeting & Inter alia, to consider and approve: - 1. To Review the performance of Non-Independent Directors & the Board as a whole; 2. To Review the performance of the Chairperson of the company, taking into account the views of Executive Directors and Non-Executive Directors; 3. To assess the quality, quantity and timeliness of flow of information between the management of the listed entity and the board of directors that is necessary for the board of directors to effectively and reasonably perform their duties. 4. Any other business with the permission of chair |
| 27 03 2024 | Inter alia, to consider and approve:- 1. To consider and take on record the resignation of Mr. Ulhas Deosthale from the post of Whole-Time Director; 2. To consider and take on record the resignation of Ms. Heta Shah from the post of Company Secretary and Compliance Officer; 3. To consider and approve the appointment of Company Secretary and Compliance Officer in place of Ms. Heta Shah; 4. Any other business with the permission of Chairperson. |
| 12 11 2024 | Quarterly Results |
| 10 02 2025 | Quarterly Results |
| 24 03 2025 | Independent Director Meeting |
| 21 05 2025 | Audited Results |
| 07 08 2025 | Quarterly Results |
| 02 09 2025 | Inter alia, to consider and approve:- 1. To Fix the Day, Date, Time and Mode of 33rd Annual General Meeting of the Company for the year ended March 31, 2025 and approve Draft notice and Calendar of Events for the same. 2. To Fix the Cut- off date to determine the entitlement of voting rights of members for E-voting and to fix the commencement and closing date for E-voting. 3. To consider and approve the Directors Report for the year ended March 31, 2025. 4. To consider and approve Annual Report for Financial Year 2024-25. 5. To approve closure of Share Transfer Books & Register of Members for the 33rd Annual General Meeting. 6. To Consider and approve the appointment of Scrutinizer for E-voting at the ensuing 33rd Annual General Meeting. 7. Any other Matter with the permission of the Chairman. |
| 06 11 2025 | Quarterly Results |
| 09 02 2026 | Quarterly Results |
News
